The $1.7 trillion revenue prescription drug industry has a relatively robust immunity to tariffs. Last Wednesday, when U.S.

Introduction Pharma 4.0 refers to the digital transformation of pharmaceutical manufacturing, integrating advanced technologies such as AI, IoT ...